Correlation Between Vaxcyte and Karuna Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vaxcyte and Karuna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and Karuna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxcyte and Karuna Therapeutics, you can compare the effects of market volatilities on Vaxcyte and Karuna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of Karuna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and Karuna Therapeutics.
Diversification Opportunities for Vaxcyte and Karuna Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Vaxcyte and Karuna is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and Karuna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karuna Therapeutics and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with Karuna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karuna Therapeutics has no effect on the direction of Vaxcyte i.e., Vaxcyte and Karuna Therapeutics go up and down completely randomly.
Pair Corralation between Vaxcyte and Karuna Therapeutics
If you would invest 3,788 in Vaxcyte on December 12, 2024 and sell it today you would earn a total of 3,197 from holding Vaxcyte or generate 84.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Vaxcyte vs. Karuna Therapeutics
Performance |
| Timeline |
| Vaxcyte |
| Karuna Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Vaxcyte and Karuna Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaxcyte and Karuna Therapeutics
The main advantage of trading using opposite Vaxcyte and Karuna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, Karuna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karuna Therapeutics will offset losses from the drop in Karuna Therapeutics' long position.| Vaxcyte vs. Larimar Therapeutics | ||
| Vaxcyte vs. Syndax Pharmaceuticals | ||
| Vaxcyte vs. Merus BV | ||
| Vaxcyte vs. Sutro Biopharma |
| Karuna Therapeutics vs. Blueprint Medicines Corp | ||
| Karuna Therapeutics vs. Amylyx Pharmaceuticals | ||
| Karuna Therapeutics vs. Day One Biopharmaceuticals | ||
| Karuna Therapeutics vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |